Zinger Key Points
- Bon announced it won a $12 million supply agreement to co-develop apple polyphenol-infused health solutions.
- The company will co-develop the aforementioned health solutions for Shanghai Yunsheng, a Chinese functional ingredients distributor.
- Today's manic market swings are creating the perfect setup for Matt’s next volatility trade. Get his next trade alert for free, right here.
Bon Natural Life Limited BON stock is moving higher on Friday after the company announced it won a $12 million supply agreement to co-develop apple polyphenol-infused health solutions.
What To Know: Bon won a 24-month long supply agreement to co-develop the aforementioned health solutions for Shanghai Yunsheng, a Chinese functional ingredients distributor.
The partnership will leverage Bon’s patented extraction technology to deliver formulations that combine antioxidant-rich apple polyphenols with plant-based proteins.
“As one of the world’s premier apple polyphenol suppliers, we’re leveraging our vertically integrated supply chain to dominate this high-growth niche,” said Yongwei Hu, Chairman and CEO of Bon.
Bon shares are trading on unusually high volume, with 285.79 million shares exchanged. The company's 100-day average is 15.27 million, according to data from Benzinga Pro.
BON Price Action: At the time of writing, Bon shares are trading 55.1% higher at 9 cents, per data from Benzinga Pro.
Image: This illustration was generated using artificial intelligence via Midjourney.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.